2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 (589-592)
АУТОР(И) / AUTHOR(S): Milan Beljkas, Jelena Rebić, Milica Radan, Teodora Đikić, Slavica Oljačić, Katarina Nikolic
Е-АДРЕСА / E-MAIL: milan.beljkas@pharmacy.bg.ac.rs
DOI: 10.46793/ICCBI23.589B
САЖЕТАК / ABSTRACT:
Overexpression of Rho-associated protein kinases has been associated with various diseases, including tumors. None of the approved ROCK inhibitors are used for cancer treatment. However, some of them have been shown to have anti-tumor potential. The main objective of this study was to develop novel ROCK1 inhibitors using the structure-based method, molecular docking, and prediction of pharmacokinetic properties using the ADMET predictor. The key interactions that strongly correlate with the activity of ROCK1 inhibitors are hydrogen bonds between amino acid residues Met156, Glu154 and the hinge region of the inhibitors, indicating possible structural changes in the hinge region of studied compounds. On the other hand, the lack of interactions between 1,3-benzoxadiol moiety and the enzyme presents a promising approach for further structural modifications in order to design more effective ROCK1 inhibitors.
All the important interactions between the developed ROCK1 inhibitors and the binding site of the enzyme were established. They also showed acceptable pharmacokinetic properties and could be further used for synthesis and evaluation by various biological assays.
КЉУЧНЕ РЕЧИ / KEYWORDS:
molecular docking, ADME, design, ROCK1
ЛИТЕРАТУРА / REFERENCES:
- Wei, Lei, et al. „Novel insights into the roles of Rho kinase in cancer.“ Archivum immunologiae et therapiae experimentalis 64 (2016): 259-278.
- Ying, Han, et al. „The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.“ Molecular cancer therapeutics 5.9 (2006): 2158-2164.
- Jones, Gareth, et al. „Development and validation of a genetic algorithm for flexible docking.“ Journal of molecular biology 267.3 (1997): 727-748.
- MarvinSketch 5.5.1.0. ChemAxon, Budapest, Hungary, 2011; software available at https://www.chemaxon.com
- Stewart, James JP. „I. Method Ati 2/L5 Z 9″ 0.“ Journal of Computational Chemistry 10.2 (1989): 209-220.
- Discovery Studio Predictive Science Application | Dassault Systèmes BIOVIA https://3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/ (accessed Jun 25, 2023)
- ADMET Predictor, v. 10.3, Simulations Plus Inc., Lancaster, CA, USA,
https://www.simulations-plus.com - Shen, Mingyun, et al. „Discovery of novel ROCK1 inhibitors via integrated virtual screening strategy and bioassays.“ Scientific reports 5.1 (2015): 16749